BioNxt Solutions Inc.
BNXTF
$0.25
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.05M | -1.54M | -1.16M | -939.80K | -1.38M |
| Total Depreciation and Amortization | 800.00 | 3.20K | 4.00K | 4.90K | -4.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.44M | 682.10K | 276.70K | 284.90K | 793.60K |
| Change in Net Operating Assets | 185.90K | 68.70K | -587.70K | 102.00K | -330.30K |
| Cash from Operations | -423.00K | -786.00K | -1.47M | -547.90K | -916.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 50.70K | 2.70K | 35.30K | 1.30K | 58.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | -36.30K | -- | -- |
| Cash from Investing | 50.70K | 2.70K | -1.00K | 1.30K | 58.00K |
| Total Debt Issued | -- | 0.00 | 1.25M | 0.00 | 3.39M |
| Total Debt Repaid | -- | 0.00 | 0.00 | -1.71M | -1.71M |
| Issuance of Common Stock | 474.80K | 677.90K | 1.36M | 431.50K | 135.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -115.00K | 1.71M | -288.80K |
| Cash from Financing | 341.40K | 486.30K | 1.81M | 311.90K | 1.06M |
| Foreign Exchange rate Adjustments | -100.00 | 300.00 | 300.00 | 0.00 | 600.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.10K | -296.60K | 337.30K | -234.80K | 206.80K |